You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematological malignancies.

Showing 3751 - 3775 of 3,813
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Pain Trial in Saffron Walden (AD 923)

Terminated
  • Cancer
  • Pain
  • AD 923
  • Saffron Walden, Essex, United Kingdom
    Sosei R&D Ltd
Jun 5, 2008

Biliary Obstruction Trial in Cape Town (SEMS)

Unknown status
  • Biliary Obstruction
  • SEMS
  • Cape Town, Western Cape, South Africa
    Groote Schuur Hospital
Aug 5, 2008

Multiple Myeloma Trial in Baltimore (bortezomib)

Completed
  • Multiple Myeloma
  • Baltimore, Maryland
    Sinai Hospital of Baltimore
Feb 7, 2008

11C-Acetate PET/CT Non-FDG-Avid Tumors

Unknown status
  • Soft Tissue Sarcomas
  • +9 more
    • Tel Aviv, Israel
      Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center
    May 30, 2008

    Leukemia, Lymphoma, Meningeal Tumors Trial run by the NCI (topotecan)

    Completed
    • Leukemia
    • +2 more
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Mar 3, 2008

    Peripheral Blood Lymphocytes and Marrow Progenitor Cells From

    Completed
    • Chronic Myeloid Leukemia
    • +3 more
      • Bethesda, Maryland
        National Cancer Institute (NCI)
      Mar 3, 2008

      Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in United States (Expansion of umbilical cord

      Completed
      • Acute Lymphocytic Leukemia
      • +4 more
      • Expansion of umbilical cord stem cells
      • Maywood, Illinois
      • +3 more
      Apr 11, 2007

      Hematologic Diseases Trial in Genoa (Intrabone Marrow Injection)

      Unknown status
      • Hematologic Diseases
      • Intrabone Marrow Injection
      • Genoa, Italy
        A.O. San Martino - Dep. Center Stem cells and cell therapy"
      Jun 9, 2008

      Non-Hodgkin's Lymphoma Trial in United States (autologous immunoglobulin idiotype-KLH conjugate vaccine)

      Terminated
      • Non-Hodgkin's Lymphoma
      • autologous immunoglobulin idiotype-KLH conjugate vaccine
      • Los Angeles, California
      • +8 more
      Mar 14, 2008

      Kidney Failure,Chronic Trial in Taipei (Physioneal)

      Completed
      • Kidney Failure,Chronic
      • Taipei, Taiwan
        Taiwan Universithy Hospital
      May 4, 2008

      Nephroblastoma, Neuroblastoma Trial run by the NCI (IFN-alpha with retinoic acid)

      Completed
      • Nephroblastoma
      • Neuroblastoma
      • IFN-alpha with retinoic acid
      • Bethesda, Maryland
        National Cancer Institute (NCI)
      Mar 3, 2008

      Cancer, Non-Myeloid Malignancies Trial (rHuEPO, Darbepoetin alfa)

      Completed
      • Cancer
      • Non-Myeloid Malignancies
      • (no location specified)
      Feb 20, 2008

      Kidney Diseases Trial run by the NCI (carboxypeptidase-G2)

      Completed
      • Kidney Diseases
      • Bethesda, Maryland
        National Cancer Institute (NCI)
      Mar 3, 2008

      Hyperuricemia Trial in Seoul (Rasburicase)

      Completed
      • Hyperuricemia
      • Seoul, Korea, Republic of
        Sanofi-Aventis
      Jan 24, 2008

      Advanced Malignancies Trial in Philadelphia (WX-UK1 in combination with Capecitabine)

      Completed
      • Advanced Malignancies
      • WX-UK1 in combination with Capecitabine
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center
      Jan 21, 2008

      Patient With Invasive Cervical Carcinoma, Patient With CIN Lesion, Patient With HPV Infected Patients Without Histopathologic

      Unknown status
      • Patient With Invasive Cervical Carcinoma
      • +3 more
      • peripheral blood isolation
      • Taipei, Taiwan
        National Taiwan University Hospital
      May 6, 2008

      Melanocytic Nevi in Children Under Chemotherapy

      Completed
      • Nevus, Pigmented
        • Graz, Austria
          Department of Dermatology, Medical University of Graz
        Jan 24, 2008

        Hematologic Diseases, MDS Trial run by the CC (Antithymocyte globulin, Cyclosporine)

        Completed
        • Hematologic Diseases
        • Myelodysplastic Syndromes
        • Bethesda, Maryland
          Warren G. Magnuson Clinical Center (CC)
        Mar 3, 2008

        Lymphoma, Melanoma, Tumor Metastasis Trial run by the NCI (COL-3)

        Completed
        • Lymphoma
        • +3 more
        • Bethesda, Maryland
          National Cancer Institute (NCI)
        Mar 3, 2008

        HIV, Immunologic Deficiency Syndromes, Lymphoproliferative Disorders Trial run by the NCI (all-trans-retinoic acid with

        Completed
        • HIV Infections
        • +2 more
        • all-trans-retinoic acid with IFN-alpha2a
        • Bethesda, Maryland
          National Cancer Institute (NCI)
        Mar 3, 2008

        Assessment of Regulatory Immune Cell Populations After

        Unknown status
        • Allogeneic Hematopoietic Cell Transplant Recipients
          • Vienna, Austria
          • +1 more
          Jan 4, 2008

          Inherited Urologic Malignant Disorders: Collection of Samples

          Completed
          • Neoplastic Syndromes, Hereditary
          • Urologic Neoplasms
            • Bethesda, Maryland
              National Cancer Institute (NCI)
            Mar 3, 2008

            Gynecological Malignancies, Genital Tumors, Female, Anemia Trial (darbepoetin alfa, recombinant human erythropoietin (rHuEPO))

            Completed
            • Gynecological Malignancies
            • +2 more
            • darbepoetin alfa
            • recombinant human erythropoietin (rHuEPO)
            • (no location specified)
            Dec 20, 2007

            Tumors Trial in Taipei (Immune profiling and DC vaccine)

            Unknown status
            • Neoplasms
            • Immune profiling and DC vaccine
            • Taipei, Taiwan
              Mackay Memorial Hospital
            Feb 29, 2008

            Hairy Cell Leukemia Trial run by the NCI (Roferon-A)

            Completed
            • Hairy Cell Leukemia
            • Bethesda, Maryland
              National Cancer Institute (NCI)
            Mar 3, 2008